VINBLASTINE‐LOADED PLATELET TRANSFUSION IN AN ALLOIMMUNIZED PATIENT
暂无分享,去创建一个
K. Itoh | K. Hiruma | H. Wakita | H. Nakamura | T. Asai | P. Wong | S. Yoshida | Nobuyuki Endoh
[1] C. Richard,et al. THE USEFULNESS OF 1,25‐DIHYDROXY‐VITAMIN D3 (1,25(OH)2 vit D3) IN THE TREATMENT OF IDIOPATHIC MYELOFIBROSIS , 1986, British journal of haematology.
[2] A. Azzará,et al. 1,25-dihidroxy-vitamin d3 (1,25(OH)2D3) in the treatment of idiopathic myelofibrosis , 1986 .
[3] R. Ross,et al. A significant part of macrophage-derived growth factor consists of at least two forms of PDGF , 1985, Cell.
[4] J. Reilly,et al. Endothelial cell proliferation in myelofibrosis , 1985, British journal of haematology.
[5] H. DeLuca,et al. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues. , 1984, Cancer research.
[6] E. Scott,et al. Platelet transfusion therapy in an alloimmunized patient. The value of crossmatch procedures for donor selection. , 1982, JAMA.
[7] A. Manoharan,et al. The Reticulin Content of Bone Marrow in Acute Leukaemia in Adults , 1979, British journal of haematology.
[8] Deborah S. Smith,et al. The treatment of idiopathic thrombocytopenia with vinblastine-loaded platelets. , 1978, The New England journal of medicine.
[9] A. Rimm,et al. Successful transfusion of platelets “mismatched” for HLA antigens to alloimmunized thrombocytopenic patients , 1977, American journal of hematology.